Dublin, Aug. 28, 2020 (GLOBE NEWSWIRE) -- The "Global Automated Insulin Delivery (AID) Market: Size & Forecast with Impact Analysis of COVID-19 (2020-2024)" report has been added to ResearchAndMarkets.com's offering.
This report provides an in-depth analysis of the global automated insulin delivery (AID) market with description of market sizing and growth. Furthermore, the report also provides detailed analysis of the market by value, by device, by diabetes, by end-user and by region.
Moreover, the report also assesses the key opportunities in the market and outlines the factors that are and would be driving the growth of the industry. Growth of the overall global automated insulin delivery (AID) market has also been forecasted for the years 2020-2024, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.
Some of the major players operating in the global automated insulin delivery (AID) market are Medtronic Plc, Eli Lilly and Company, Novo Nordisk and Biocon, whose company profiling has been done in the report. Furthermore, in this segment of the report, business overview, financial overview and business strategies of the respective companies are also provided.
Region Coverage
- Asia Pacific
- North America
- Europe
- Latin America
- Middle East & Africa
Automated insulin delivery (AID) is also known as hybrid or full closed loop, artificial pancreas system (APS), looping, etc. Automated insulin delivery (AID) is a method for managing diabetes but it is not same for every patient. Patients have choices, ranging from the type of insulin pump and continuous glucose monitor (CGM) patient want to use. In addition, technology has advanced the regulation of blood glucose concentrations, minimized the frequency of hyperglycaemic and improved the quality of life of people with diabetes.
There are different algorithms which are proposed for artificial pancreas system, which includes proportional integral derivative (PID) algorithms, model predictive control (MPC) algorithms and fuzzy logic algorithms.
Moreover, on the basis of devices, automated insulin delivery (AID) can be segmented into hybrid closed loop and fully closed loop devices, whereas, on the basis of end-user, automated insulin delivery (AID) can be bifurcated into hospitals, retail medical stores, health centers and others.
The global automated insulin delivery (AID) market has progressed promptly over the years and the market is further anticipated to escalate during the forecasted years 2020 to 2024. The market would augment owing to numerous growth drivers such as the increasing diabetic population, growth in geriatric population, rising global healthcare expenditure, surging obese population, change in lifestyle of people globally, etc.
However, the market faces some challenges which are hindering the growth of the market. Some of the major challenges faced by the industry are oral insulin and regulatory compliance problems. Moreover, the market growth would also succeed by various market trends like rising adoption of wearable healthcare devices and novel product launches.
Key Topics Covered:
1. Executive Summary
2. Introduction
2.1 Insulin Delivery Devices: An Overview
2.2 Different Insulin Delivery Devices
2.3 Automated Insulin Delivery Devices: An Overview
2.4 Important Algorithms Proposed for Artificial Pancreas System
2.5 Comparison of MPC, PID, and Fuzzy-Logic Algorithms
2.6 Automated Insulin Delivery Segmentation
3. Global Market Analysis
3.1 Global Automated Insulin Delivery (AID) Market: An Analysis
3.1.1 Global Automated Insulin Delivery (AID) Market by Value
3.1.2 Global Automated Insulin Delivery (AID) Market by Device (Hybrid Closed Loop and Fully Closed Loop)
3.1.3 Global Automated Insulin Delivery (AID) Market by Diabetes (Type I Diabetes and Type II Diabetes)
3.1.4 Global Automated Insulin Delivery (AID) Market by End-User (Hospital, Retail Medical Store, Health Center and Other)
3.1.5 Global Automated Insulin Delivery (AID) Market by Region (North America, Europe, Asia Pacific, Latin America and Middle East & Africa)
3.2 Global Automated Insulin Delivery (AID) Market: Device Analysis
3.2.1 Global Hybrid Closed Loop AID Market by Value
3.2.2 Global Fully Closed Loop AID Market by Value
3.3 Global Automated Insulin Delivery (AID) Market: Diabetes Analysis
3.3.1 Global Automated Insulin Delivery (AID) Type I Diabetes Market by Value
3.3.2 Global Automated Insulin Delivery (AID) Type II Diabetes Market by Value
3.4 Global Automated Insulin Delivery (AID) Market: End-User Analysis
3.4.1 Global Hospital Automated Insulin Delivery (AID) Market by Value
3.4.2 Global Retail Medical Store Automated Insulin Delivery (AID) Market by Value
3.4.3 Global Health Centre Automated Insulin Delivery (AID) Market by Value
4. Regional Market Analysis
4.1 North America Automated Insulin Delivery (AID) Market: An Analysis
4.1.1 North America Automated Insulin Delivery (AID) Market by Value
4.1.2 North America Automated Insulin Delivery (AID) Market by Device
4.1.3 North America Hybrid Closed Loop AID Market by Value
4.1.4 North America Fully Closed Loop AID Market by Value
4.1.5 North America Automated Insulin Delivery (AID) Market by Diabetes
4.1.6 North America Automated Insulin Delivery (AID) Type I Diabetes Market by Value
4.1.7 North America Automated Insulin Delivery (AID) Type II Diabetes Market by Value
4.1.8 North America Automated Insulin Delivery (AID) Market by End User
4.1.9 North America Hospital Automated Insulin Delivery (AID) Market by Value
4.1.10 North America Retail Medical Store Automated Insulin Delivery (AID) Market by Value
4.1.11 North America Health Centre Automated Insulin Delivery (AID) Market by Value
4.1.12 North America Automated Insulin Delivery (AID) Market by Countries
4.1.13 The US Automated Insulin Delivery (AID) Market by Value
4.1.14 Canada Automated Insulin Delivery (AID) Market by Value
4.2 Europe Automated Insulin Delivery (AID) Market: An Analysis
4.2.1 Europe Automated Insulin Delivery (AID) Market by Value
4.2.2 Europe Automated Insulin Delivery (AID) Market by Devices
4.2.3 Europe Hybrid Closed Loop AID Market by Value
4.2.4 Europe Fully Closed Loop AID Market by Value
4.2.5 Europe Automated Insulin Delivery (AID) Market by Diabetes
4.2.6 Europe Automated Insulin Delivery (AID) Type I Diabetes Market by Value
4.2.7 Europe Automated Insulin Delivery (AID) Type II Diabetes Market by Value
4.2.8 Europe Automated Insulin Delivery (AID) Market by End User
4.2.9 Europe Hospital Automated Insulin Delivery (AID) Market by Value
4.2.10 Europe Retail Medical Store Automated Insulin Delivery (AID) Market by Value
4.2.11 Europe Health Centre Automated Insulin Delivery (AID) Market by Value
4.2.12 Europe Automated Insulin Delivery (AID) Market by Countries
4.2.13 Germany Automated Insulin Delivery (AID) Market by Value
4.2.14 France Automated Insulin Delivery (AID) Market by Value
4.2.15 UK Automated Insulin Delivery (AID) Market by Value
4.2.16 Italy Automated Insulin Delivery (AID) Market by Value
4.2.17 Spain Automated Insulin Delivery (AID) Market by Value
4.3 Asia Pacific Automated Insulin Delivery (AID) Market: An Analysis
4.3.1 Asia Pacific Automated Insulin Delivery (AID) Market by Value
4.3.2 Asia Pacific Automated Insulin Delivery (AID) Market by Devices
4.3.3 Asia Pacific Hybrid Closed Loop AID Market by Value
4.3.4 Asia Pacific Fully Closed Loop AID Market by Value
4.3.5 Asia Pacific Automated Insulin Delivery (AID) Market by Diabetes
4.3.6 Asia Pacific Automated Insulin Delivery (AID) Type I Diabetes Market by Value
4.3.7 Asia Pacific Automated Insulin Delivery (AID) Type II Diabetes Market by Value
4.3.8 Asia Pacific Automated Insulin Delivery (AID) Market by End User
4.3.9 Asia Pacific Hospital Automated Insulin Delivery (AID) Market by Value
4.3.10 Asia Pacific Retail Medical Store Automated Insulin Delivery (AID) Market by Value
4.3.11 Asia Pacific Health Centre Automated Insulin Delivery (AID) Market by Value
4.3.12 Asia Pacific Automated Insulin Delivery (AID) Market by Countries
4.3.13 Japan Automated Insulin Delivery (AID) Market by Value
4.3.14 China Automated Insulin Delivery (AID) Market by Value
4.3.15 India Automated Insulin Delivery (AID) Market by Value
4.3.16 Australia Automated Insulin Delivery (AID) Market by Value
4.3.17 South Korea Automated Insulin Delivery (AID) Market by Value
4.4 Latin America Automated Insulin Delivery (AID) Market: An Analysis
4.4.1 Latin America Automated Insulin Delivery (AID) Market by Value
4.5 Middle East & Africa Automated Insulin Delivery (AID) Market: An Analysis
4.5.1 Middle East & Africa Automated Insulin Delivery (AID) Market by Value
5. COVID-19
5.1 Impact of Covid-19
5.2 Response of Industry to Covid-19
5.3 Variation in Organic Traffic
6. Market Dynamics
6.1 Growth Drivers
6.1.1 Increasing Diabetic Population
6.1.2 Growth in Geriatric Population
6.1.3 Surging Obese Population
6.1.4 Rising Global Healthcare Expenditure
6.1.5 Change in Lifestyle
6.2 Challenges
6.2.1 Oral Insulin
6.2.2 Regulatory Compliance Problem
6.3 Market Trends
6.3.1 Rising Adoption of Wearable Healthcare Devices
6.3.2 Novel Product Launches
7. Competitive Landscape
7.1 Global Automated Insulin Delivery (AID) Market Players: A Financial Comparison
7.2 Global Insulin Pump Installed Base Unit Market Share by Players
7.3 Global Insulin Pump Sales Market Share by Players
8. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/abx9fv
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.